Showing results (71-80 of 89) with videos related to

Sort By:
Pageof 9
American Journal of Medical Genetics. Part A|September 12, 2012
Beyond Gómez-López-Hernández syndrome: recurring phenotypic themes in rhombencephalosynapsisHannah M Tully, Jennifer C Dempsey, Gisele E Ishak, et al.
European Journal of Nutrition|November 22, 2018
Hydroxytyrosol inhibits cancer stem cells and the metastatic capacity of triple-negative breast cancer cell lines by the simultaneous targeting of epithelial-to-mesenchymal transition, Wnt/β-catenin and TGFβ signaling pathwaysMarina Cruz-Lozano, Adrián González-González, Juan A Marchal, et al.
Critical Reviews in Oncology/Hematology|December 30, 2008
Elderly patients with advanced colorectal cancer derive similar benefit without excessive toxicity after first-line chemotherapy with oxaliplatin-based combinations: comparative outcomes from the 03-TTD-01 phase III studyJavier Sastre, Enrique Aranda, Bartomeu Massutí, et al.
Oncotarget|October 4, 2014
EMT and EGFR in CTCs cytokeratin negative non-metastatic breast cancerMaria J Serrano, Francisco G Ortega, Maria J Alvarez-Cubero, et al.
Pharmaceuticals (Basel, Switzerland)|September 28, 2024
Association of the Serotonin and Kynurenine Pathways as Possible Therapeutic Targets to Modulate Pain in Patients with FibromyalgiaAlfonso Alfaro-Rodríguez, Samuel Reyes-Long, Ernesto Roldan-Valadez, et al.
Sensors (Basel, Switzerland)|October 12, 2017
Micro and Nanostructured Materials for the Development of Optical Fibre SensorsCesar Elosua, Francisco Javier Arregui, Ignacio Del Villar, et al.
Pharmaceutics|August 23, 2020
Bioreactor-Grown Bacillus of Calmette and Guérin (BCG) Vaccine Protects Badgers against Virulent Mycobacterium bovis When Administered Orally: Identifying Limitations in Baited Vaccine DeliverySandrine Lesellier, Colin P D Birch, Dipesh Davé, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 19, 2007
The African Millennium VillagesPedro Sanchez, Cheryl Palm, Jeffrey Sachs, et al.
Plos One|July 14, 2017
PTCH1 is a reliable marker for predicting imatinib response in chronic myeloid leukemia patients in chronic phaseJuan M Alonso-Dominguez, Luis Felipe Casado, Eduardo Anguita, et al.
Brain Communications|August 13, 2025
Rare PANK2 variants and pantothenate-kinase-associated neurodegeneration in the Dominican RepublicBadri N Vardarajan, Pedro Sanchez Roa, Christine Y Kim, et al.
Pageof 9